通过分泌组分析鉴定MYH9作为滑膜细胞迁移和侵袭的关键调节因子
本研究通过液相色谱-串联质谱分析类风湿关节炎(RA)滑膜成纤维细胞(RA-FLSs)的分泌组,鉴定出843种分泌蛋白,其中48.5%与侵袭性血管翳病理相关。平行反应监测分析发现包括MYH9在内的16种关键蛋白与侵袭性血管翳相关,MYH9在RA-FLSs和RA滑膜中表达升高,并由白细胞介素-1β、肿瘤坏死因子α、Toll样受体连接和内质网刺激诱导分泌。功能实验表明MYH9促进RA-FLSs体外和人源化滑膜炎模型中的迁移和侵袭,该作用可被MYH9特异性抑制剂blebbistatin显著抑制。
要点
- RA-FLSs分泌组含843种蛋白,48.5%与血管翳驱动病理相关。
- MYH9在RA-FLSs和RA滑膜中表达升高,其分泌由IL-1β、TNFα等诱导。
- MYH9促进RA-FLSs迁移和侵袭,blebbistatin可显著抑制。
核心结论
- 本研究提供了RA-FLSs来源分泌组的综合资源,并提示MYH9是延缓RA-FLSs异常迁移和侵袭的有前景靶点。
研究设计与样本
- 研究采用液相色谱-串联质谱分析RA-FLSs分泌蛋白,并行超声评估关节滑膜炎严重程度。
- 通过ELISA、蛋白质印迹和免疫染色检测RA-FLSs和滑膜组织中MYH9表达水平。
- 在免疫缺陷小鼠中诱导人源化滑膜炎模型。
主要发现
- 从RA-FLSs中鉴定出843种分泌蛋白,其中48.5%与血管翳驱动病理相关。
- 平行反应监测分析发现16种与侵袭性血管翳相关的关键蛋白,包括MYH9,其反映基于超声的滑膜病理和关节炎症活动。
- MYH9在培养的RA-FLSs和RA滑膜中表达升高,其分泌由白细胞介素-1β、肿瘤坏死因子α、Toll样受体连接和内质网刺激诱导。
- MYH9促进RA-FLSs体外和人源化滑膜炎模型中的迁移和侵袭,blebbistatin可显著抑制该作用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: 'Invasive pannus' is a pathological hallmark of rheumatoid arthritis (RA). This study aimed to investigate secretome profile of synovial fibroblasts of patients with RA (RA-FLSs), a major cell type comprising the invasive pannus. METHODS: Secreted proteins from RA-FLSs were first identified using liquid chromatography-tandem mass spectrometry analysis. Ultrasonography was performed for affected joints to define synovitis severity at the time of arthrocentesis. Expression levels of myosin heavy chain 9 (MYH9) in RA-FLSs and synovial tissues were determined by ELISA, western blot analysis and immunostaining. A humanised synovitis model was induced in immuno-deficient mice. RESULTS: We first identified 843 proteins secreted from RA-FLSs; 48.5% of the secretome was associated with pannus-driven pathologies. Parallel reaction monitoring analysis of the secretome facilitated discovery of 16 key proteins related to 'invasive pannus', including MYH9, in the synovial fluids, which represented synovial pathology based on ultrasonography and inflammatory activity in the joints. Particularly, MYH9, a key protein in actin-based cell motility, showed a strong correlation with fibroblastic activity in the transcriptome profile of RA synovia. Moreover, MYH9 expression was elevated in cultured RA-FLSs and RA synovium, and its secretion was induced by interleukin-1β, tumour necrosis factor α, toll-like receptor ligation and endoplasmic reticulum stimuli. Functional experiments demonstrated that MYH9 promoted migration and invasion of RA-FLSs in vitro and in a humanised synovitis model, which was substantially inhibited by blebbistatin, a specific MYH9 inhibitor. CONCLUSIONS: This study provides a comprehensive resource of the RA-FLS-derived secretome and suggests that MYH9 represents a promising target for retarding abnormal migration and invasion of RA-FLSs.
引用
- Lee S, Choi E, Chae S, et al. Identification of MYH9 as a key regulator for synoviocyte migration and invasion through secretome profiling. Ann Rheum Dis. 2023. PMID: 37188496. doi:10.1136/ard-2022-223625
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。